Observational Trial With Leios/Alesse

This study has been completed.

First Received on May 31, 2007. Last Updated on December 7, 2007 History of Changes

Sponsor:	Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:	Wyeth is now a wholly owned subsidiary of Pfizer
ClinicalTrials.gov Identifier:	NCT00481650

Purpose

A prospective, observational study (Anwendungsbeobachtung [AWB]) of the prescribing and administration practices of German gynecologists with Leios® Dragées.

Condition	Intervention	Phase
Contraceptives, Oral, Combined	Drug: Leios/Alesse	Phase IV

Study Type:	Observational
Study Design:	Time Perspective: Prospective
Official Title:	A Prospective Observation Study (Anwendungsbeobachtung [AWB]) of the Prescribing and Administration Practices of German Gynecologists With Leios® Dragées/Alesse

Resource links provided by NLM:

Drug Information available for: Ethinyl estradiol-norgestrel combination

U.S. FDA Resources

Further study details as provided by Wyeth is now a wholly owned subsidiary of Pfizer:

Study Start Date:	May 2005
Study Completion Date:	March 2007

Eligibility

Ages Eligible for Study:	up to 40 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Healthy, women, aged under 40

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00481650

Sponsors and Collaborators

Wyeth is now a wholly owned subsidiary of Pfizer

Investigators

Study Director:	Medical Monitor	Wyeth is now a wholly owned subsidiary of Pfizer
Principal Investigator:	Trial Manager	For Germany, medinfoDEU@wyeth.com

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00481650 History of Changes
Other Study ID Numbers:	101742
Study First Received:	May 31, 2007
Last Updated:	December 7, 2007
Health Authority:	Germany: Federal Institute for Drugs and Medical Devices

Additional relevant MeSH terms:

Ethinyl Estradiol-Norgestrel Combination
Ethinyl estradiol, levonorgestrel drug combination
Contraceptives, Oral, Combined
Contraceptives, Oral
Contraceptive Agents, Female
Contraceptive Agents
Reproductive Control Agents

Physiological Effects of Drugs
Pharmacologic Actions
Therapeutic Uses
Contraceptives, Oral, Synthetic
Contraceptives, Postcoital, Synthetic
Contraceptives, Postcoital

ClinicalTrials.gov processed this record on February 09, 2012